The Compliance and Enforcement Group (COEN) published a guidance for the “Instructions For Use for reusable and re‐sterilisable Medical Devices” containing a checklist for the IFU base on the EN ISO 17664 and checklist for the assessment of the validation of reprocessing procedures based on the EN ISO 14937.
The Scientific Committee on Health, Environmental and Emerging Risks SCHEER released guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties.
The British MHRA gives a statement on certificates being issued by certification bodies headed “certificates of compliance” or “Attestation of Compliance”. They are aware that these certificates are not evidence that the manufacturer has met the regulatory requirements and should not be taken as proof of such.
The Swiss Federal Council approved the new Medical Device Ordinance (MedDO) and the new Ordinance on Clinical Trials for Medical Devices (ClinO-MD). The new version of the MedDO integrates the MDR into the national law and thereby it keeps Switzerland in the EU market for medical devices.
The European Commission released an analysis of the “Availability and capacity of notified bodies to carry out conformity assessments for COVID-19 related medical devices and in vitro diagnostic medical devices”. This document is based on a survey conducted with notified bodies in charge of the certification of COVID-19-related medical devices and in vitro diagnostic medical devices.
The FDA published a new guidance document on “Multiple Function Device Products: Policy and Considerations”. Products with at least one device function and at least one "other function" are referred to in this guidance as "multiple function device products." The purpose of this guidance is to identify the principles, premarket review practices, and policies for FDA's regulatory assessment of such products and to provide examples of the application of these policies.
The FDA added new standards to their database of Recognized Consensus Standards, e.g. in the following fields:
The FDA also added more categories of Class II medical devices that are exempt from 510(k) premarket notification. Some of the categories have limitations to the exemption though. The categories are:
Last but not least the FDA announced a their new user fees payable starting from October 1st. Medical device companies pay fees e.g. for the registration of their establishments or for listing of their devices when they submit an application or a notification to market a new medical device in the USA.
The Australian TGA provides information about 3-D printing (additive manufacturing) of medical devices to assist manufacturers with addressing the relevant risks and meeting the Australian regulatory requirements for medical devices.
Some delays to the commencement of certain medical device regulatory changes were announced by the TGA, e.g. for the reclassification of certain devices, for medical device software, personalised medical devices (including 3D printed devices) and systems or procedure packs.
You can download all Regulatory Affairs Updates compiled for you as a PDF under the following link.